Anthony Tutino
7Patents
3h-index
8Co-inventors
42Inventor score
Filing activity: May 19, 2010 → May 10, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8828427B2 | Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione | Emerging Cross-Sectional Technologies | 28 | Active |
| US8603527B2 | Pharmaceutical formulations of a substituted diaminopurine | Human Necessities | 16 | Active |
| US9198866B2 | Pharmaceutical formulations of a substituted diaminopurine | Human Necessities | 15 | Active |
| US9393255B2 | Pharmaceutical compositions of cytidine analogs and methods of use thereof | Human Necessities | 1 | Active |
| US9993467B2 | Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione | Emerging Cross-Sectional Technologies | 1 | Active |
| US9468605B2 | Formulations of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione | Human Necessities | 1 | Active |
| US10555939B2 | Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.